Physician profile
Michael Macbrayne
NPI 1932420379
$872.22
in general payments reported to CMS, 2019-2025
13 companies · $33.48 in 2025
The $33.48 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $497 · 2022: $260 · 2023: $38.74 · 2024: $43.17 · 2025: $33.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $115.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $469.51 | 2021-2022 | |
| Abbott Laboratories | $121.16 | 2021-2025 | Freestyle Libre 2, Freestyle Libre 3 |
| Vertos Medical, INC. | $60.02 | 2023-2024 | Mild Device Kit |
| Neurocrine Biosciences, INC. | $46.10 | 2021 | |
| Amgen INC. | $41.54 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $26.29 | 2021-2022 | |
| Eisai INC. | $19.44 | 2021 | |
| Janssen Pharmaceuticals, INC | $16.65 | 2021 | |
| Sunovion Pharmaceuticals INC. | $16.49 | 2021 | |
| Exact Sciences Corporation | $16.01 | 2025 | Cologuard Collection Kit |
| Jazz Pharmaceuticals INC. | $13.08 | 2021 | |
| Alkermes, INC. | $13.03 | 2021 | |
| Lilly USA, LLC | $12.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Macbrayne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.